Oncternal Therapeutics Inc (ONCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,703 | -15,470 | -50,336 | -2,384 | -39,411 |
| Depreciation Amortization | 43 | 36 | 29 | 17 | 102 |
| Accounts payable and accrued liabilities | -130 | -328 | 285 | -74 | -296 |
| Other Working Capital | -1,027 | -998 | -1,117 | -130 | -3,104 |
| Other Operating Activity | -218 | 1,929 | 41,282 | -2,124 | 13,950 |
| Operating Cash Flow | $-20,035 | $-14,831 | $-9,857 | $-4,695 | $-28,759 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 16,215 | 8,752 | 6,304 | 978 | -31,215 |
| PPE Investments | -4 | -4 | -4 | N/A | -5 |
| Investing Cash Flow | $16,211 | $8,748 | $6,300 | $978 | $-31,220 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -2 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 63,949 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -617 |
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $63,330 |
| Beginning Cash Position | 17,880 | 17,880 | 17,880 | 17,880 | 14,529 |
| End Cash Position | 14,056 | 11,797 | 14,323 | 14,163 | 17,880 |
| Net Cash Flow | $-3,824 | $-6,083 | $-3,557 | $-3,717 | $3,351 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,035 | -14,831 | -9,857 | -4,695 | -28,759 |
| Capital Expenditure | -4 | -4 | -4 | 0 | -5 |
| Free Cash Flow | -20,039 | -14,835 | -9,861 | -4,695 | -28,764 |